Skip to main content
Clinical Trials/CTRI/2023/04/052058
CTRI/2023/04/052058
Not yet recruiting
Phase 4

A comparative evaluation of two different doses of magnesium sulfate as an adjuvant to bupivacaine in transversus abdominis plane block for postoperative analgesia in caesarean section: A randomized, double-blind, superiority trial

DrVijeta Bajpai0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
DrVijeta Bajpai
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
DrVijeta Bajpai

Eligibility Criteria

Inclusion Criteria

  • 1 18 \- 35 years females belonging to the American Society of Anesthesiologists (ASA) Class I/II
  • 2 Elective or Emergency LSCS under Subarachnoid block.
  • 3 Normal bleeding profile.
  • 4 No history of relevant drug allergy.
  • 5 Patients willing to participate in the study.

Exclusion Criteria

  • 1 Age \<18 and \>35 years.
  • 2 Patient refusal.
  • 3 Significant cardiovascular disease, hepatic dysfunction or renal dysfunction
  • 4 Coagulation abnormalities and Bleeding disorder
  • 5 Infection in the intended intervention site
  • 6 Patient on intravenous MgSO4
  • 7 Eclamptic or preeclamptic patient

Outcomes

Primary Outcomes

Not specified

Similar Trials